REVEALED: Annals of internal medicine | Vintage Vibes

A new biweekly GLP-1 drug called bofanglutide showed strong blood sugar and weight loss results in a Phase 2b trial. Monthly injectables and oral pills are also in the pipeline.

A 23-year trial found one sigmoidoscopy reduced colon cancer risk by 28% and death by 37% in men. Here's what this means for people who haven't been screened.

The epidemiology of food and drink is a mess.

The black fungus Candida auris, which is rapidly spreading across the US, 'colonises' the patient's skin before finding its way into the blood stream through open wounds and, if this happens there is a 30 to 60 percent mortality rate

Unlocking the health benefits of your morning cup(s) of joe

Merck & Co Inc (NYSE:MRK) and Ridgeback Biotherapeutics announced that the Annals of Internal Medicine had published additional data from the Phase 3 MOVe-OUT trial of Lagevrio (molnupiravir) in non-hospitalized COVID-19 patients at high risk for progressing to severe disease. A lower proportion of molnupiravir-treated participants in the modified intent-to-treat population had an acute care…

Coffee drinkers are up to a third less likely to die young, even if they add sugar to the popular brew, researchers claim. This study, published in the journal Annals of Internal Medicine, is the first to link sugary coffee with health benefits, claims Dr Liu.

A new study has found that in comparison to non-coffee drinkers, adults who drank moderate amounts (1.5 to 3.5 cups per day) of unsweetened coffee or coffee sweetened with sugar were less likely to die during a 7-year follow-up period. Full story on Dynamite News:

A new study suggests that two-thirds of these victims are women.